tiprankstipranks
Neurogene (NGNE)
NASDAQ:NGNE
US Market
NGNE
Neurogene
RESEARCH TOOLSreports

Neurogene (NGNE) Stock News & Sentiment

608 Followers
3 Best High-Risk, High-Reward Stocks to Buy Now, According to Analysts – 4/9/2026
Premium
Market News
3 Best High-Risk, High-Reward Stocks to Buy Now, According to Analysts – 4/9/2026
2d ago
UPB
AIOT
Buy Rating Backed by Strong NGN-401 Clinical Progress, De-Risking Efficacy Data, and Solid Cash Runway in Rett Syndrome
Premium
Ratings
Buy Rating Backed by Strong NGN-401 Clinical Progress, De-Risking Efficacy Data, and Solid Cash Runway in Rett Syndrome
17d ago
NGNE
Buy Rating Underpinned by De-Risked NGN‑401 Development, Aligned Manufacturing Strategy, and Cash Runway Through Key 2027–28 Catalysts
Premium
Ratings
Buy Rating Underpinned by De-Risked NGN‑401 Development, Aligned Manufacturing Strategy, and Cash Runway Through Key 2027–28 Catalysts
18d ago
NGNE
Neurogene Advances Rett Gene Therapy Toward BLA With Strong Cash Runway
Premium
Company Announcements
Neurogene Advances Rett Gene Therapy Toward BLA With Strong Cash Runway
18d ago
NGNE
1 Top Stock to Buy Now with 350% Upside, 3/24/2026, According to Top Analysts
Premium
Market News
1 Top Stock to Buy Now with 350% Upside, 3/24/2026, According to Top Analysts
18d ago
NGNE
NGNE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
NGNE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
22d ago
NGNE
Neurogene Gains FDA Breakthrough Status for Rett Gene Therapy
Premium
Company Announcements
Neurogene Gains FDA Breakthrough Status for Rett Gene Therapy
1M ago
8K
NGNE
More NGNE News >

NGNE News on the Web

3 Best High-Risk, High-Reward Stocks to Buy Now, According to Analysts – 4/9/2026
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE), Alzamend Neuro (ALZN) and Cardiol Therapeutics (CRDL)
TipRanks News
Neutral
Neurogene price target lowered to $180 from $200 at Canaccord
TipRanks News
Neutral
Canaccord Genuity Remains a Buy on Neurogene (NGNE)
TipRanks News
Bearish
Neurogene Executives Quietly Offload Shares in a Wave of Insider Selling
TipRanks News
Neutral
Neurogene (NGNE) Receives a Buy from LifeSci Capital
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE), Vertex Pharmaceuticals (VRTX) and Sarepta Therapeutics (SRPT)
TipRanks News
Bullish
Buy Rating Backed by Strong NGN-401 Clinical Progress, De-Risking Efficacy Data, and Solid Cash Runway in Rett Syndrome
TipRanks News
Bullish

News Score - Last 7 Days

Negative
NGNE
Sector Average
Media Buzz
This Week4 articles
Weekly Average4.25 articles
News Sentiment
This Week0%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NGNE’s Media Buzz Sentiment?
4 articles about NGNE were published this week. In an average week, 4.25 articles are published.
    What is NGNE’s weekly average amount of articles?
    In an average week, 4.25 articles about NGNE are published.
      What is NGNE’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      AORTArtivion
      NBIXNeurocrine
      STAAStaar Surgical
      SLPSimulations Plus
      OWLTOwlet
      Showing the stocks with the most bullish news sentiment over the past week